Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
RELX
RELX
$62.5B
| $17.1M | 0.01% |
511,700
+180,390
| +54% | +$5.81M |
|
1502
Roivant Sciences
ROIV
$26.3B
| $17.1M | 0.01% |
1,695,976
+1,287,479
| +315% | +$11.5M |
|
1503
Omega Healthcare
OHI
$14.2B
| $17.1M | 0.01% |
556,365
-919,406
| -62% | -$26.6M |
|
1504
Krispy Kreme
DNUT
$618M
| $17.1M | 0.01% |
1,159,091
+486,490
| +72% | +$7.29M |
|
1505
Tidewater
TDW
$4.59B
| $17.1M | 0.01% |
307,763
+297,480
| +2,893% | +$13.6M |
|
1506
Fluence Energy
FLNC
$1.61B
| $17M | 0.01% |
637,582
+448,977
| +238% | +$10M |
|
1507
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $17M | 0.01% |
209,381
+110,610
| +112% | +$9.04M |
|
1508
Rockwell Automation
ROK
$47.7B
| $17M | 0.01% |
51,529
+28,662
| +125% | +$8.28M |
|
|
EVRI
1509
DELISTED
Everi Holdings
EVRI
| $17M | 0.01% |
1,172,936
+363,204
| +45% | +$5.52M |
|
1510
Liberty Media Series C
FWONK
$26.2B
| $16.9M | 0.01% |
232,859
+171,050
| +277% | +$12.2M |
|
1511
AGNC Investment
AGNC
$12.9B
| $16.9M | 0.01% |
1,671,224
-2,945,355
| -64% | -$28.6M |
|
1512
PUT
SLB Ltd
SLB
$79.1B
| $16.9M | 0.01% |
344,100
+36,200
| +12% | +$1.73M |
|
1513
PUT
Manulife Financial
MFC
$71.6B
| $16.9M | 0.01% |
675,000
-900,000
| -57% | -$17.2M |
|
1514
Cytokinetics
CYTK
$10.8B
| $16.8M | 0.01% |
516,465
+293,770
| +132% | +$10.9M |
|
1515
Kosmos Energy
KOS
$1.63B
| $16.8M | 0.01% |
2,809,570
+1,688,883
| +151% | +$11M |
|
1516
Waters Corp
WAT
$40.7B
| $16.8M | 0.01% |
63,113
-512,883
| -89% | -$143M |
|
|
GHIX
1517
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $16.8M | 0.01% |
1,640,000
-40,000
| -2% | -$407K |
|
1518
PUT
Shift4
FOUR
$3.79B
| $16.8M | 0.01% |
+247,500
| New | +$16.2M |
|
1519
Credo Technology Group
CRDO
$42.2B
| $16.8M | 0.01% |
967,671
+493,411
| +104% | +$5.87M |
|
1520
NexGen Energy
NXE
$7.52B
| $16.8M | 0.01% |
3,551,283
+3,520,476
| +11,428% | +$14.3M |
|
1521
PUT
Rithm Capital
RITM
$5.68B
| $16.8M | 0.01% |
1,792,600
+57,700
| +3% | +$482K |
|
1522
PUT
Marathon Petroleum
MPC
$99.7B
| $16.7M | 0.01% |
143,400
+71,900
| +101% | +$8.36M |
|
1523
Louisiana-Pacific
LPX
$5.06B
| $16.7M | 0.01% |
222,887
-349,450
| -61% | -$21.6M |
|
1524
CALL
ON Semiconductor
ON
$28.2B
| $16.7M | 0.01% |
176,400
-109,500
| -38% | -$9.06M |
|
1525
Doximity
DOCS
$4.41B
| $16.7M | 0.01% |
490,336
+375,082
| +325% | +$12.5M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.